Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Predictive Oncology Inc
POAICurrent price
1.06 USD
-0.04 USD (-3.64%)
Last closed
0.96 USD
Company
www.predictive-oncology.com
ISIN
US74039M3097
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
Capitalization
9 735 466 USD
Yield for 12 month
-20.90 %
1Y
3Y
5Y
10Y
15Y
POAI
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania. Address: 91 43rd Street, Pittsburgh, PA, United States, 15201
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.00 USDP/E ratio
–Dividend Yield
–Current Year
+1 623 817 USD
Last Year
+1 780 093 USD
Current Quarter
+611 585 USD
Last Quarter
+345 686 USD
Current Year
+797 680 USD
Last Year
+1 145 297 USD
Current Quarter
+320 959 USD
Last Quarter
+148 767 USD
Key Figures POAI
1 year
3 years
5 years
10 years
EBITDA
-10 777 391 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-70.52 %
PEG Ratio
–
Return On Equity TTM
-269.18 %
Wall Street Target Price
3.00 USD
Revenue TTM
1 623 817 USD
Book Value
-0.031 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
91.40 %
Dividend Yield
–
Gross Profit TTM
797 680 USD
Earnings per share
-1.99 USD
Diluted Eps TTM
-1.99 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics POAI
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History POAI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:20
Payout Ratio TTM
–
Last Split Date
24.04.2023
Stock Valuation POAI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.86
Price Sales TTM
6.00
Enterprise Value EBITDA
-0.51
Price Book MRQ
1.43
Financials POAI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators POAI
For 52 weeks
0.55 USD
2.59 USD
50 Day MA
1.25 USD
Shares Short Prior Month
395 788
200 Day MA
1.03 USD
Short Ratio
0.14
Shares Short
1 054 841
Short Percent
11.96 %
BeatStart